20212024年苏州市人类免疫缺陷病毒抗体确证阳性病例的T淋巴细胞亚群水平及病毒载量

Analyses of T lymphocyte subset levels and viral loads in human immunodeficiency virus antibody-confirmed positive cases in Suzhou from 2021 to 2024

  • 摘要:
    目的 了解2021—2024年苏州市新发现人类免疫缺陷病毒(HIV)抗体确证试验阳性病例的T淋巴细胞亚群水平和病毒载量,结合病例的人口学特征、免疫状态和体内病毒复制情况,分析可能的影响因素,为艾滋病(AIDS)防治工作提供依据。
    方法 采集2021—2024年苏州市新发现HIV抗体确证试验阳性病例的外周全血样本,开展T淋巴细胞亚群和病毒载量检测,结合人口学特征分析影响因素,并使用logistic回归模型对CD4+T淋巴细胞≤350个·μL-1的影响因素进行分析,使用Spearman秩相关检验对病毒载量的对数值与CD4+/CD8+比值的相关性进行分析。
    结果 3 022份HIV确证阳性病例样本CD4+T淋巴细胞计数中位数为298.00个·μL-1,CD4+T淋巴细胞计数<200个·μL-1的有882份,占29.19%,CD8+T淋巴细胞计数中位数为1 011.00个·μL-1,CD4+/CD8+比值的中位数为0.28,比值<0.20的样本占32.46%,不同性别、年龄、婚姻状况和样本来源组间的CD4+/CD8+比值差异均有统计学意义(均P<0.05)。多因素logistic回归分析显示,年龄≥20岁、离异或丧偶者及样本来源为医疗机构者,相较于<20岁、未婚及样本来源于自愿咨询检测门诊者,其CD4+T淋巴细胞≤350个·μL-1的占比更高。病毒载量对数值的均数为(4.29±1.15)拷贝数·mL-1,病毒载量对数值与CD4+/CD8+比值(r=-0.43,P<0.001)和CD4+T淋巴细胞计数(r=-0.37,P<0.001)负相关。
    结论 苏州市新发现的HIV感染者/AIDS患者中存在晚发现情况,病毒载量水平较高,需重点关注高风险人群,及时主动监测和干预,联合开展T淋巴细胞亚群和病毒载量检测,尽早发现和治疗患者。

     

    Abstract:
    Objective To investigate the T lymphocyte subset levels and viral loads in newly human immunodeficiency virus (HIV) antibody-confirmed positive cases in Suzhou (2021‒2024), and to analyze potential influencing factors by integrating their demographic characteristics, immune status, and viral replication patterns, thereby providing evidence for HIV/acquired immune deficiency syndrome (AIDS) prevention and control.
    Methods Peripheral whole blood samples were collected from newly confirmed HIV-positive cases in Suzhou from 2021 to 2024. T lymphocyte subset analysis and viral load testing were performed, and influencing factors were identified in combination with demographic characteristics. Logistic regression models were employed to identify factors associated with CD4+T lymphocyte counts ≤350 cells·μL-1, and Spearman’s rank correlation test was used to analyze the correlation between logarithmic value of viral load and CD4+/CD8+ ratio.
    Results Among the 3 022 confirmed HIV-positive samples, the median CD4+T lymphocyte count was 298.00 cells·μL-1, with 882 cases (29.19%) showing CD4+ T lymphocyte counts <200 cells·μL-1. The median CD8+T lymphocyte count was 1 011.00 cells·μL-1. The median CD4+/CD8+ ratio was 0.28, with 32.46% of cases exhibiting CD4+/CD8+ ratios <0.20, and there were statistically significant differences in CD4+/CD8+ ratio among different genders, age groups, marital status, and sample sources (all P<0.05). Multivariate logistic regression analyses indicated that individuals aged ≥20 years, those who were divorced or widowed, and cases identified through medical institutions had a significantly higher proportion of CD4+T lymphocyte counts ≤350 cells·µL⁻¹ compared to those aged <20 years, unmarried individuals, and cases sourced from voluntary counseling and testing (VCT) clinics, respectively. The mean logarithmic value of viral load was (4.29±1.15) copies·mL-1. The logarithmic value of viral load demonstrated a significantly negative correlation with both CD4+/CD8+ ratio (r=-0.43, P<0.001) and CD4+T lymphocyte count (r=-0.37, P<0.001).
    Conclusion A substantial proportion of newly diagnosed HIV/AIDS cases in Suzhou are late presenters with high viral load levels. Targeted interventions should prioritize high-risk populations through enhanced active surveillance and the implementation of combined T lymphocyte subsets analysis and viral load testing, which can enable earlier case-finding and timely antiretroviral therapy initiation.

     

/

返回文章
返回